title: Heparin-mediated inhibition of PCR in the accelerated phase of chronic myeloid leukaemia characterised by abundant basophilia.
authors.affiliation: Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.
authors.forename: Yumiko
authors.initials: Y
authors.lastname: Satoh
authors.forename: Akiko
authors.initials: A
authors.lastname: Masuda
authors.forename: Masahiro
authors.initials: M
authors.lastname: Jona
authors.forename: Yasuhito
authors.initials: Y
authors.lastname: Nannya
authors.forename: Hiromitsu
authors.initials: H
authors.lastname: Yokota
authors.forename: Mineo
authors.initials: M
authors.lastname: Kurokawa
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Yatomi
mesh_terms: D000369:Aged, 80 and over; D016477:Artifacts; D001491:Basophils / Q000378:metabolism / Q000473:pathology; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000032:analysis* / Q000235:genetics; D015870:Gene Expression; D006493:Heparin / Q000737:chemistry* / Q000378:metabolism; D019763:Heparin Lyase / Q000737:chemistry; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology; D007958:Leukocyte Count; D018365:Neoplasm, Residual / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology; D016133:Polymerase Chain Reaction / Q000592:standards*
chemical_list: C581634:BCR-ABL1 fusion protein, human; D006493:Heparin; D016044:Fusion Proteins, bcr-abl; D019763:Heparin Lyase